Tag:

Pulmonary Disease

Latest Headlines

Gilead, Parion partner on pulmonary disease

August 16, 2007

Parion Sciences has signed on Gilead to partner up on pulmonary disease therapies. Gilead will pay $5 million up front and $5 million in exchange for an equity stake in Parion for worldwide

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Senior Manager, Global Market Insights Job
Celgene Corporation - Summit, NJ, US
Food Development Scientist Job
Yoh - Park Ridge, NJ, USA
Aseptic Operations Manager
DPT Labs - Lakewood, NJ
Senior Manager, API Development
TESARO - Waltham, MA
Project Manager, Marketing Excellence Job
Celgene Corporation - Summit, NJ, US

Pulmonary Disease

Latest Headlines

Latest Headlines

Gilead, Parion partner on pulmonary disease

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Pulmonary Disease

Latest Headlines

Latest Headlines

Gilead, Parion partner on pulmonary disease

Related Tags